Cancer in the Liver
Prospective Analysis of Liver Cancer Treatments and Interventions - (J0671) Active
Molecular Basis of Hepatobiliary Malignancies - (J0674) Active
Evaluation of tumor response to transcatheter arterial chemoembolization with imaging modalities - (Z0611) Active
Research database and study examining the correlation between dosimetric parameters and clinical outcome among patients with primary or metastatic liver cancer treated with radioembolization at Johns Hopkins - (J11148) Active
Lipiodol as an imaging biomarker of tumor necrosis after transcatheter chemoembolization therapy in patients with primary and metastatic liver cancer - (J12115) Active
Hepatocellular Carcinoma (HCC)
Global investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with Sorafenib (GIDEON) - (J0905) Completed enrolment
Phase II Trial of Sorafenib Combined with Doxorubicin Eluting Bead-Transarterial Chemoembolization (LC Bead-TACE) for Patients with Hepatocellular Carcinoma - (J08110) Completed enrolment
Doxorubicin-eluting LC Bead M1 for patients with hepatocellular carcinoma - (J1306) Active
A Phase III Randomized, Double-Blind Trial of Chemoembolization with or without Sorafenib in Unresectable Hepatocellular Carcinoma (HCC) in Patients with and without Vascular Invasion - (E1208) Active
Pilot Clinical Evaluation of uTASWako i30 Lens Culinaris Agglutinin-Reactive Î±-Fetoprotein (AFP-L3) and Des-Î³-Carboxy Prothrombin (DCP) Assay in the Diagnosis of Hepatocellular Carcinoma (HCC) - (J1250) Active
Neuroendocrine Metastases (NET)
Treatment of Patients with Hepatic Neuroendocrine Metastases using Drug-Eluting Bead Embolization - (J0739) Active
Colorectal Carcinoma (CRC)
A Phase III Clinical Trial Evaluating TheraSphere in Patients with Metastatic Colorectal Carcinoma of the Liver who have Failed First Line Chemotherapy (EPOCH) - (J1210) Active
Irinotecan-eluting LC Bead-M1 (DEBIRI-M1) for Patients with Liver Metastases from Colorectal Cancer - (J1305) Active
If you would like more information, please call Diane Reyes at (410) 614-4212. You may also contact Dr. Geschwind or Dr. Schlachter.
Benign Prostatic Hypertrophy (BPH)
Prospective, Randomized, Controlled Investigation Of Prostate Artery Embolization With Embosphere Microspheres Compared To Transurethral Resection Of The Prostate For The Treatment Of Symptomatic Benign Prostatic Hyperplasia - Active
If you would like more information, please email email@example.com or call 410-614-9261.
Philips Pivotal Clinical Trial Protocol for MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids - Active
If you would like more information, please call 410-614-2227 and/or Contact Dr. Hong.
Development of Image Guided Interventional Techniques - Active
If you would like more information, please Contact Dr. Weiss.